Pharmaceutical Consulting

Navigating pharmaceutical markets across China and the Asia-Pacific region requires more than ambition. With complex regulatory frameworks, evolving pricing systems, and competitive dynamics, companies need more than just local presence, they need a partner with deep industry knowledge, robust strategy, and executional strength.

Cisema offers pharmaceutical consulting services that help companies in the pharmaceutical industry, including biotech, gene therapy, and life sciences innovators, prepare for market entry, accelerate approvals, and optimize commercialization across the region. We support clients with a comprehensive understanding of regulatory pathways, drug development stages, and clinical research demands.

Chinese testing
Pharmaceutical Market Access Consulting
Pharma and Biotech Innovation

Our services include:

Regulatory strategy and planning to reduce risks and eliminate uncertainty
Accelerated registration pathways to shorten time-to-market streamline the drug development process
End-to-end compliance support to meet regional requirements and safeguard operations
Market access strategies tailored to to maximize value, patient reach, and commercial success.

Whether you’re initiating clinical trials, navigating drug registration, or expanding across Asia Pacific, we deliver targeted solutions and proven results across all stages of development.

Work with Cisema to stay ahead of regulatory trends, reduce time-to-market, and achieve sustainable success across China and the broader Asia-Pacific region.

Discover Our Pharmaceutical Consulting Services

Pharmaceutical Development & Strategy

Drive successful market entry and growth with confidence. Our pharmaceutical regulatory consulting experts support biotech and life sciences companies in streamlining drug development, accelerating approvals, and achieving commercialization through tailored strategies, clinical insights, and end-to-end compliance solutions.

Scientific, Technical & Clinical Due Diligence
Development Strategy & Gap Analysis
Regulatory and Clinical Strategy Development
Health Authority Interaction
Scientific, Medical, Technical & Regulatory Writing

Health Economics & Market Access

Accelerate access across China and Asia Pacific with confidence. Our market access consultants help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.

Market Intelligence
Pricing and Reimbursement (P&R) Landscape Analysis
Strategic Market Entry & Pricing Models
Reimbursement Strategy
Competitive Dynamics Assessment
Stakeholder Engagement & Market Insights

Pharmaceutical Regulatory Affairs

Navigate regulatory complexity across China and Asia Pacific with confidence. Our regulatory affairs consulting experts support life sciences clients with strategic planning, compliant submissions, and local representation to accelerate approvals and ensure market readiness.

Scientific, Technical and Regulatory Strategy
Procedure Management
CMC & Compliance
Health Authority Interaction
Labeling Management & Promotional Material Review
Legal Agent / Domestic Responsible Agent

Pharmaceutical Quality Management & Compliance

Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences organizations strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.

Review, Assessment & Pre-audits of GxP/QMS/SOPs
Ingredient Compliance Analysis
Vendor Audit and Management
Pre-approval Inspection
China & overseas factory audits
Official NMPA Inspection Assistance

Pharmacovigilance

Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.

Signal Management
Risk Management
Case Safety Report Management
Clinical Trial Safety
Pharmacovigilance System Audit & CAPA
Post-Marketing Surveillance

Why Cisema?

Cisema brings together regional expertise, industry insights, and operational excellence to support pharmaceutical success. We work closely with our clients to address regulatory, strategic, and quality challenges, ensuring timely approvals, sustainable market access, and efficient commercialization. Our consultants are trusted by leaders across the life sciences industry for their depth of experience and commitment to quality outcomes.


We help you:

Prepare your product pipeline for China and the Asia Pacific region
Develop effective strategies aligned with local healthcare policy
Respond quickly to evolving trends and regulatory shifts
Navigate compliance requirements with confidence
Optimize clinical trial processes, data use, and real-world evidence

Whether your focus is innovation, access, or long-term growth, our consulting solutions are built to deliver measurable results.

Pharma and healthcare expertise from the Cisema team

Request a Proposal from Our Pharma Team

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More

What Are Malaysia NPRA’s License Requirements for Pharmaceutical Products?

Learn about NPRA license requirements in Malaysia, including license types, application steps, fees, processing timelines, renewals, and new application requirements.

August 31, 2026
What Are Malaysia NPRA’s License Requirements for Pharmaceutical Products?

How Does GBA Real World Data Support China NMPA Approvals?

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

July 31, 2026
How Does GBA Real World Data Support China NMPA Approvals?

China NMPA Fee Catalogue for Drugs & Medical Devices

Learn the latest China NMPA registration fees for imported and domestic drugs and medical devices.

July 10, 2026
China NMPA Fee Catalogue for Drugs & Medical Devices

How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

This guide explains Singapore’s HSA regulatory system and why it is a strategic first step for entering Southeast Asian markets with medical devices, pharmaceuticals, and cosmetics.

July 9, 2026
How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

A Complete Guide to China Hyaluronic Acid Registration

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

July 9, 2026
A Complete Guide to China Hyaluronic Acid Registration

A Guide to Malaysia Drug–Medical Device Combination Products: Classification & Regulatory Pathways

Learn how Malaysia classifies drug–medical device combination products and how the PMOA determines pathways and compliance responsibilities.

July 9, 2026
A Guide to Malaysia Drug–Medical Device Combination Products: Classification & Regulatory Pathways
Laboratory professional in protective eyewear, hair cover, sterile gown, and blue nitrile gloves examining a filled syringe in a clean laboratory environment.
Previous
Previous

Other Industries We Support

In addition to pharmaceuticals and biotech, we offer consulting services across regulated industries, including medical devices, IVDs, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Medical Devices

In-Vitro Diagnostics

Biotech

Cosmetics

Health Foods & Supplements

Veterinary Medicines & Products

Industrial Goods & Consumer Products

Latest Insights

View More

Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

Circular No. 2/2026 revises prohibited, restricted, colorant, and preservative requirements for cosmetics marketed in Malaysia.

August 20, 2026
Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?

Brands must audit ingredients, suppliers and packaging before January 2028 to ensure compliance with GB 7916-2026.

August 18, 2026
China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?
Scientist in clean modern room inspects cosmetics.

China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Companies can benefit from expanded toxicology data exemptions, simplified cosmetics registration procedures, and more efficient compliance pathways

August 18, 2026
China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories

August 18, 2026
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

August 18, 2026
China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed
This stock photo features a close-up, high-angle shot focusing on a skincare product arrangement set against a light-colored, wood-grain surface.

NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

August 18, 2026
NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria
Previous
Previous

Get in Touch with Our Pharmaceutical Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex pharmaceutical regulatory environment of China and the Asia Pacific region.

Request Proposal